[go: up one dir, main page]

Kaufman et al., 1983 - Google Patents

Herpes simplex keratitis

Kaufman et al., 1983

Document ID
3383186596527425320
Author
Kaufman H
Centifanto-Fitzgerald Y
Varnell E
Publication year
Publication venue
Ophthalmology

External Links

Snippet

Avirulent strains of herpes simplex type 1 (HSV-1) infect and shed and colonize the ganglia in rabbits. This primary infection reduces the severity of subsequent infection by virulent virus and prevents ganglionic colonization by even very virulent neurotropic virus. Only a …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00—Drug, bio-affecting and body treating compositions
    • Y10S514/931—Veneral disease
    • Y10S514/934—Virus

Similar Documents

Publication Publication Date Title
Stevens et al. Maintenance of latent herpetic infection: an apparent role for anti-viral IgG
DE69125925T2 (en) RECOMBINANT HERPES SIMPLEX VIRUS VACCINE AND METHODS
Stanberry Pathogenesis of herpes simplex virus infection and animal models for its study
Berman et al. Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs
Centifanto-Fitzgerald et al. Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strains
US7785605B2 (en) Herpes simplex virus mutant ICP0 protein
US7025970B2 (en) Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods
Kaufman et al. Herpes simplex keratitis
Perng et al. The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34. 5 gene is not involved in spontaneous reactivation
Klein et al. Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice
Trousdale et al. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl) thymine against herpes simplex virus in cell cultures and rabbit eyes
CA2101075C (en) Peptides for the treatment of conditions caused by herpes virus infections
Gerstein et al. Phosphonoacetic acid in the treatment of experimental herpes simplex keratitis
US8802109B2 (en) Herpes simplex virus mutant ICP0
Thygeson et al. Observations on uveitis associated with viral disease
KAUFMAN Chemotherapy of herpes keratitis
Klein et al. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment
Klein et al. Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice
Lausch et al. Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice
Baker et al. Resistance of female mice to vaginal infection induced by Herpesvirus hominis type 2: effects of immunization with Mycobacterium bovis, intravenous injection of specific Herpesvirus hominis type 2 antiserum, and a combination of these procedures
Kaye et al. Non-traumatic acquisition of herpes simplex virus infection through the eye.
Klein et al. Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate
Metcalf et al. Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins
Hughes Treatment of herpes simplex keratitis: a review
Schinazi et al. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs